6Narayan P, Amit G. Fungal Peritonitis in peritoneal dialysis patients[J]. Peritoneal Dialysis International, 2005, 25:207-222.
7Ahn C, Oh K H, Kim K, et al. Effet of peritoneal dialysis on plasna and peritomeal fluid concentrations of isoniozid, pyrazinanide,and rifanpin[J]. Perit Dial Int, 2003, 23:362-367.
8Mujais S. Microbiology and outcomes of peritonitis in North America[J]. Kidney Int Suppl, 2006, 103:S55-62.
9Gadallah M F, Randeen G, Mignone J. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters[J]. Am J Kidney Dis, 2000, 36:1014-1019.
6Lysaght M J. Maintenance dialysis population dynamics: current trends and long-term implications[J]. J Am Soc Nephrol,2002,12 suppl 1 :S37-40.
7Javaid B, Quigg R J. Trealment of glomerulonephrilis: will we ever have options other than steroids and cytotoxics [J]?Kidney Inl, 2005,67(5):1692-703.
8Guan Y, Breyer M D. Peroxisome proliferator-activated receptors(PPARs): novel therapeutic targets in renal disease[J]. Kidney Int,2001,60(1):14-30.
9Weiner D E, Sarnak M J. Managing dyslipidemia in chronic kidney disease[J]. J Gen Intern Med,2004,19(10):1045-52.
10Pierratos A. New approaches to hemodialysis[J]. Annu Rev Med,2004,55:179-89.
